Retrospective Study
Copyright ©The Author(s) 2025.
World J Gastrointest Oncol. Apr 15, 2025; 17(4): 101487
Published online Apr 15, 2025. doi: 10.4251/wjgo.v17.i4.101487
Table 4 Factors associated with false-positive and false-negative fecal immunological test for the detection of advanced colorectal neoplasm
Variables
False-positive FIT (true negative as reference)
False-negative FIT (true positive as reference)
Crude OR (95%CI)
Adjusted OR (95%CI)
P value
Crude OR (95%CI)
Adjusted OR 95%CI)
P value
Age (per additional year)1.02 (1.01-1.02)1.01 (1.01-1.02)< 0.0010.96 (0.94-0.97)0.96 (0.94-0.97)< 0.001
Sex
    Female1111
    Male1.06 (1.01-1.12)0.91 (0.85-0.96)0.0010.97 (0.82-1.15)1.23 (1.00-1.49)0.045
Smoking status
    Never smoker1111
    Former smoker1.48 (1.29-1.69)1.39 (1.21-1.60)< 0.0010.73 (0.51-1.06)1.03 (0.68-1.55)0.881
    Current smoker1.41 (1.31-1.51)1.36 (1.26-1.48)< 0.0010.69 (0.56-0.83)0.73 (0.57-0.95)0.017
    Never drinker1111
    Ever drinker1.48 (1.35-1.62)1.3 (1.17-1.44)< 0.0010.53 (0.42-0.68)0.60 (0.45-0.81)< 0.001
Physical activity
    Irregular exercise1111
    Regular exercise1.00 (0.95-1.05)0.90 (0.85-0.95)< 0.0010.84 (0.71-10)1.07 (0.88-1.31)0.474
BMI (kg/m2)
    < 251111
    25-29.91.23 (1.16-1.30)1.18 (1.11-1.25)< 0.0010.69 (0.58-0.82)0.75 (0.61-0.91)0.004
    ≥ 301.51 (1.35-1.69)1.42 (1.27-1.59)< 0.0010.47 (0.33-0.67)0.56 (0.38-0.83)0.004
Hemorrhoid
    No1111
    Yes1.86 (1.74-1.99)1.85 (1.73-1.97)< 0.0010.36 (0.28-0.45)0.58 (0.46-0.74)< 0.001
Diverticulum
    No1111
    Yes1.47 (1.22-1.77)1.26 (1.04-1.52)0.0180.44 (0.25-0.80)0.75 (0.41-1.39)0.359
Presence of nonadvanced adenoma
    No11
    Yes1.07 (1.01-1.13)0.99 (0.94-1.05)0.753
Presence of any advanced adenoma ≥ 10 mm
    No11
    Yes0.21 (0.18-0.25)0.08 (0.06-0.12)< 0.001
Presence of any advanced adenoma of high-grade dysplasia
    No11
    Yes0.68 (0.49-0.94)0.66 (0.45-0.98)0.041
Presence of any advanced adenoma with villous/tubulovillous features
    No11
    Yes0.62 (0.40-0.97)0.76 (0.44-1.31)0.248
Presence of CRC
    No11
    Stage 0-I CRC1.13 (0.81-1.58)0.13 (0.08-0.22)< 0.001
    Stage II-IV CRC2.13 (1.70-2.67)0.26 (0.17-0.39)< 0.001